These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4697)

  • 1. [Modern aspects in the therapy of obstructive lung diseases].
    Renovanz HD
    Med Monatsschr; 1975 Oct; 29(10):437-40. PubMed ID: 4697
    [No Abstract]   [Full Text] [Related]  

  • 2. Newer medications to aid treatment of asthma.
    Brandon ML
    Ann Allergy; 1977 Aug; 39(2):117-29. PubMed ID: 18958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating the elderly asthmatic patient.
    Bardana EJ
    Compr Ther; 1984 Jul; 10(7):15-23. PubMed ID: 6146428
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects of the management of bronchial asthma and chronic obstructive lung disease.
    Rowe WS
    Med J Aust; 1975 May; 1(20):623-5. PubMed ID: 238095
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of pharmacotherapy in the treatment of rhinitis.
    Broide D; Schatz M; Zeigler R
    Ear Nose Throat J; 1986 May; 65(5):222-6. PubMed ID: 2873019
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenetic basis of treatment for chronic obstructive pulmonary disease].
    Kozak-Szkopek E; Dworzański W; Hanzlik J
    Pol Merkur Lekarski; 1996 Jul; 1(1):56-9. PubMed ID: 9156898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchial asthma. Clinical aspects and new therapeutic trends].
    Miti L; Massei V; Sanguinetti CM; Bonifazi F
    Minerva Med; 1980 Jan; 71(3):177-86. PubMed ID: 6101912
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies.
    Skorodin MS
    Arch Intern Med; 1993 Apr; 153(7):814-28. PubMed ID: 8096690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Supplementary therapeutics in allergology].
    Colas S
    Soins; 1980 Mar; 25(6):43-5. PubMed ID: 6153817
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
    [No Abstract]   [Full Text] [Related]  

  • 11. New concepts in bronchodilator therapy.
    Owens GR
    Am Fam Physician; 1986 Jan; 33(1):218-29. PubMed ID: 2934965
    [No Abstract]   [Full Text] [Related]  

  • 12. The biochemical basis for the modulation of allergic reactions by drugs.
    Middleton E
    Pediatr Clin North Am; 1975 Feb; 22(1):111-9. PubMed ID: 238172
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allergic pulmonary diseases in childhood. Diagnostic and therapeutic results].
    Jorde W; Kersten W
    Med Klin; 1973 Jul; 68(29):961-5. PubMed ID: 4146865
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of bronchiolar obstruction with special reference to beta-adrenergic drugs].
    Cornia G; Gramiccioni E
    Minerva Med; 1976 Apr; 67(17):1110-4. PubMed ID: 4757
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal atrophy in a steroid-dependent adolescent with asthma.
    Wadia G; Arora NV; Hyde JS
    Ann Allergy; 1980 Aug; 45(2):90-4. PubMed ID: 6105832
    [No Abstract]   [Full Text] [Related]  

  • 16. Asthma: the promise of drug therapy.
    Middleton E
    Med Times; 1975 Nov; 103(11):76-87. PubMed ID: 582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Broncholytic effect of Atrovent in comparison with a combination preparation in obstructive lung diseases].
    Holzhey P
    Wien Med Wochenschr; 1975 Dec; 125(49):711-6. PubMed ID: 1229127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic respiratory insufficiency of pulmonary origin. Clinical considerations].
    Petraglia A; Cecere L; Scarpitta M; Ansalone D
    Minerva Med; 1979 Jan; 70(5):405-11. PubMed ID: 35769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of reversible obstructive airways disease.
    Weinberger M; Hendeles L; Ahrens R
    Med Clin North Am; 1981 May; 65(3):579-613. PubMed ID: 6787350
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary results of a trial on the spirometric and associated effects of a new bronchodilator, C 325 (author's transl)].
    Minette A; Marcq M; Bruninx M
    Acta Tuberc Pneumol Belg; 1974; 65(5):520-33. PubMed ID: 4466343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.